| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2009 | WO2009111260A1 Phenylsulfonamide-substituted, pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof |
| 09/11/2009 | WO2009111218A2 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | WO2009111214A1 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/11/2009 | WO2009111200A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | WO2009111159A2 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |
| 09/11/2009 | WO2009111105A1 Controlled release drug delivery systems and pharmaceutical compositions formed therewith |
| 09/11/2009 | WO2009111078A2 Combination of a ppary agonist and a dipeptidyl peptidase-inhibitor for the treatment of diabetes and obesity |
| 09/11/2009 | WO2009111064A2 Minocycline compounds and methods of use thereof |
| 09/11/2009 | WO2009111057A2 Fulvestrant formulations |
| 09/11/2009 | WO2009111056A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| 09/11/2009 | WO2009111031A2 Methods of treating vasomotor symptoms |
| 09/11/2009 | WO2009111028A1 Aurora kinase inhibitors |
| 09/11/2009 | WO2009110983A2 Retinaldehyde in the treatment of obesity, diabetes and other conditions |
| 09/11/2009 | WO2009110955A2 Ketoconazole-derivative antagonists of human pregnane x receptor and uses thereof |
| 09/11/2009 | WO2009110938A2 Novel macrocyclic polyene lactams |
| 09/11/2009 | WO2009110901A1 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur |
| 09/11/2009 | WO2009110844A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof |
| 09/11/2009 | WO2009110816A1 Pharmaceutical composition based on hepatoprotector and prebiotic, the production and use thereof |
| 09/11/2009 | WO2009110612A1 New compound derived from germinated brown rice, and agent containing said compound as an active ingredient for prevention or amelioration of neuropathy |
| 09/11/2009 | WO2009110526A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 3',5-di-2-propenyl-(1,1'-biphenyl)-2,4'-diol as active ingredient |
| 09/11/2009 | WO2009110520A1 Heterocyclic compound |
| 09/11/2009 | WO2009110519A1 Novel 1-aminocarbonylpiperidine derivative |
| 09/11/2009 | WO2009110510A1 Alkylaminopyridine derivative |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/11/2009 | WO2009110464A1 Composition for improvement in nutrition |
| 09/11/2009 | WO2009110416A1 Concomitant drug |
| 09/11/2009 | WO2009110415A1 Concomitant drug |
| 09/11/2009 | WO2009110351A1 Transdermally absorbable preparation |
| 09/11/2009 | WO2009110335A1 Chewing gum containing eucalyptus extract |
| 09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
| 09/11/2009 | WO2009110235A1 Combined use of cholestanol derivative |
| 09/11/2009 | WO2009110205A1 Agent for increasing the quantity of hyaluronic acid |
| 09/11/2009 | WO2009110041A1 Cancer therapeutic agent by agent for cancer-specific introduction of prostacyclin receptor antagonist |
| 09/11/2009 | WO2009110010A2 Stable oral dosage form |
| 09/11/2009 | WO2009110009A2 Opthalmic composition |
| 09/11/2009 | WO2009110008A1 Anti-ulcer activity of flavone analogs |
| 09/11/2009 | WO2009110007A1 Spiro derivatives of parthenin as novel anticancer agents |
| 09/11/2009 | WO2009110005A2 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 09/11/2009 | WO2009110004A1 Stable pharmaceutical compositions qf carvedilol |
| 09/11/2009 | WO2009110003A1 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders |
| 09/11/2009 | WO2009110002A1 Novel efflux pump inhibitors |
| 09/11/2009 | WO2009110000A1 Novel napthalimide-benzimidazole hybrids as potential antitumour agents and process for the preparation thereof |
| 09/11/2009 | WO2009109999A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109998A1 Novel protein tyrosine phosphatase - ib inhibitors |
| 09/11/2009 | WO2009109996A2 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination |
| 09/11/2009 | WO2009109993A1 Extended release dosage form of paliperidone |
| 09/11/2009 | WO2009109990A2 Pharmaceutical composition of pramipexole |
| 09/11/2009 | WO2009109989A1 A novel process for the preparation of ethers of dihydroartemisinin |
| 09/11/2009 | WO2009109986A1 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 09/11/2009 | WO2009109984A1 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof' |
| 09/11/2009 | WO2009109983A1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof |
| 09/11/2009 | WO2009109907A1 Novel pyrimidine-pyridine derivatives |
| 09/11/2009 | WO2009109906A1 Pyridine compounds |
| 09/11/2009 | WO2009109904A1 Novel aminomethyl benzene derivatives |
| 09/11/2009 | WO2009109900A1 Stimulation of ocular retrobulbar flow using ocular irritants |
| 09/11/2009 | WO2009109872A1 Pyridin-2-yl derivatives as immunomodulating agents |
| 09/11/2009 | WO2009109867A2 Crystal form of phenylamino pyrimidine derivatives |
| 09/11/2009 | WO2009109862A2 Improved cancer therapeutics |
| 09/11/2009 | WO2009109861A1 Methods of treatment employing prolonged continuous infusion of belinostat |
| 09/11/2009 | WO2009109850A2 A method of treating or preventing pain |
| 09/11/2009 | WO2009109844A1 Methods, dosage forms, and kits for administering ziprasidone without food |
| 09/11/2009 | WO2009109836A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles |
| 09/11/2009 | WO2009109751A1 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 09/11/2009 | WO2009109741A1 Clopidogrel solution for oral administration |
| 09/11/2009 | WO2009109710A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 09/11/2009 | WO2009109703A1 Method of producing a bran product |
| 09/11/2009 | WO2009109679A1 Use of virgin olive oil polyphenolic compounds in cancer treatment |
| 09/11/2009 | WO2009109654A2 Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1 |
| 09/11/2009 | WO2009109649A1 Improved antitumoral treatments |
| 09/11/2009 | WO2009109618A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109616A2 Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109613A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109610A1 Use of nad information inhibitors for the treatment of ischemia-reperfusion injury |
| 09/11/2009 | WO2009109608A1 Novel compounds |
| 09/11/2009 | WO2009109605A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members |
| 09/11/2009 | WO2009109596A1 Nicorandil carriers with enhanced stability |
| 09/11/2009 | WO2009109576A1 Pim kinase inhibitors and methods of their use |
| 09/11/2009 | WO2009109573A1 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases |
| 09/11/2009 | WO2009109549A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 09/11/2009 | WO2009109547A1 Pharmaceutical solutions, process of preparation and therapeutic uses |
| 09/11/2009 | WO2009109531A2 Combination therapy |
| 09/11/2009 | WO2009109525A1 Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease |
| 09/11/2009 | WO2009109524A1 Superabsorbent composition with metal salicylate for odour control |
| 09/11/2009 | WO2009109519A1 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptatke inhibitors |
| 09/11/2009 | WO2009109518A1 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/11/2009 | WO2009109517A1 Novel 3,8-diaza-bicyclo[3.2.1]octane- and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/11/2009 | WO2009109504A1 Enol carbamate derivatives as modulators of fatty acid amide hydrolase |
| 09/11/2009 | WO2009109502A1 2-aminoquinolines |
| 09/11/2009 | WO2009109501A2 Ocular pharmaceutical compositions |
| 09/11/2009 | WO2009109493A2 2-aminoquinolines |
| 09/11/2009 | WO2009109491A1 2-aminoquinoline derivatives |
| 09/11/2009 | WO2009109483A1 Leukotriene b4 inhibitors |
| 09/11/2009 | WO2009109477A1 2-aminoquinolines |
| 09/11/2009 | WO2009109476A1 Process for preparing concentrated aqueous micellar solutions |
| 09/11/2009 | WO2009109401A1 Salts of memantine and cox-inhibitors and their crystalform in the treatment of pain |
| 09/11/2009 | WO2009109390A1 Macrolide compositions having improved taste and stability |
| 09/11/2009 | WO2009109388A1 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
| 09/11/2009 | WO2009109364A1 Substituted sulfonamide derivatives |
| 09/11/2009 | WO2009109356A1 Cytostatic compositions |